Latest Regulatory News

Paladin Energy reported a strong half-year performance with uranium sales revenue climbing to US$138.3 million, driven by ramp-up at its Namibian mine and significant progress on Canadian development projects.

Manuka Resources has affirmed the material significance of a draft decision by New Zealand’s EPA declining consent for its Taranaki VTM Project, clarifying its disclosure timeline and compliance with ASX rules amid recent share price volatility.

ASX Limited reported robust first-half results with 11.2% revenue growth, while advancing a strategic reset in response to the ASIC Inquiry and pushing forward its technology modernization agenda.

ASX Limited reported robust half-year results with an 11.2% rise in operating revenue and a steady net profit, while advancing its technology upgrade and responding to regulatory scrutiny.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

Middle Island Resources has revealed extensive polymetallic soil anomalies spanning 5km at its Tisovik target in Serbia’s Bobija Project, signalling a promising expansion of mineralisation. The company plans to intensify exploration activities starting March 2026 to unlock the area’s full potential.

Axel REE is fast-tracking field recovery trials at its Caladão Project, leveraging proven in situ recovery methods and a rare gallium resource to position itself uniquely in the critical minerals space.

Matsa Resources launches a major drilling campaign at Fortitude North targeting up to 1.85 million ounces of gold, supported by a $17.5 million loan facility from major shareholder Deutsche Balaton.

MFF Capital Investments reported a 45% drop in net profit for the half year to December 2025 but declared a higher fully franked dividend, marking a milestone in its operational independence and strategic growth.

Titanium Sands Limited has responded to ASX inquiries following a sharp share price drop and increased trading volume, confirming no undisclosed price-sensitive information. The company highlighted an unrelated Sri Lankan Supreme Court petition on illegal mining near its pending Mannar Island project.

AMP Limited reported a robust FY25 with underlying NPAT up 20.8%, driven by strong cashflow growth, cost reductions, and new product launches including AMP Bank GO and AMP Lifetime Pension. The company sets a steady course for FY26 with continued focus on retirement solutions and AI-driven innovation.

Entropy Neurodynamics has been granted an Australian patent for its novel two-phase IV infusion method administering psilocybin and psilocin, securing exclusive rights through 2042 and strengthening its lead asset TRP-8803’s competitive position.